Haijun Yu

7PUBLICATIONS
14CO-AUTHORS
Molecular targetsDeep learningRadiation therapyPredictive and prognostic markersLanguage studies not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2026
Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.

|Jul 08, 2025
Comparison of Random Survival Forest Based-Overall Survival With Deep Learning and Cox Proportional Hazard Models in HER-2-Positive HR-Negative Breast Cancer.

Wenqi Cai, Yan Qi, Linhui Zheng

|Jan 22, 2024
Copper-Based Single-Atom Nanozyme System Mimicking Platelet Cells for Enhancing the Outcome of Radioimmunotherapy.

Cheng Chen, Nandi Chen, Yan Qi

|Mar 28, 2023
Immunogenic hypofractionated radiotherapy sensitising head and neck squamous cell carcinoma to anti-PD-L1 therapy in MDSC-dependent manner.

Liang Mao, Jun-Jie Zhou, Yao Xiao

|Sep 23, 2022
MT1X is an oncogene and indicates prognosis in ccRCC.

Yanpeng Ding, Jiayu Fang, Mengge Chen

|Jul 18, 2022
A Large Solitary Fibrous Tumor of the Nasal Cavity and Paranasal Sinuses Involving the Anterior Frontal Fossa: A Case Report and Review of the Literature.

Huachao Wu, Xiaoyan Hu, Wenbin Xiang

Pageof 2

Frequent Collaborators

1 joint publications

Zhi-Jun Sun

1 joint publications

Huachao Wu

1 joint publications

Jiayu Fang

1 joint publications

Conghua Xie